CLSI C62
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology.
Product Details
- Published:
- 06/21/2022
- ISBN(s):
- 9781684401550
- Number of Pages:
- 104
- File Size:
- 1 file , 6.8 MB
- Note:
- This product is unavailable in Russia, Belarus
Newborn Screening Follow-up; Approved Guideline – Third Edition, NBS02Ed3E
standard by Clinical and Laboratory Standards Institute, 04/01/2023
Laboratory Quality Control Based on Risk Management, Second Edition, EP23Ed2E
standard by Clinical and Laboratory Standards Institute, 08/01/2023